Latest News | Eris Lifesciences Acquires Oaknet Healthcare for Rs 650 Cr

New Delhi, May 4 (PTI) Eris Lifesciences on Wednesday said it has acquired Mumbai-based dermatology-focused domestic formulations company Oaknet Healthcare for Rs 650 crore.

The acquisition will be completed by way of a share purchase agreement and accordingly Oaknet will become a wholly-owned subsidiary of Eris, the drug firm said in a statement.

Also Read | Apple iPhone 13 128GB Variant Now Available at Rs 35,513; Here's How To Get It.

The deal will be financed by Rs 300 crore internal accruals and Rs 350 crore by borrowings, it added.

Eris Lifesciences Chairman & Managing Director Amit Bakshi noted that Oaknet provides the company with a robust growth platform in the areas of dermatology and cosmetology.

Also Read | Apple Employees Slam Company's New Work-From-Home Policy in Open Letter: Report.

"In line with Strides and Zomelis acquisitions, we are confident that the Oaknet transaction will create long-term value for our shareholders," he added.

With a revenue base of Rs 195 crore in FY22, Oaknet brings a well-established portfolio of leading brands in dermatology and women's health to the Eris stable, the drug firm said.

Oaknet has near 100 per cent coverage of around 11,000 dermatologists across the country, it added.

"The acquisition of Oaknet brings marquee brands like Cosvate and Cosmelite into the Eris portfolio. We expect to bring multiple value creation levers including in-house manufacturing, new product launches, expansion of field force productivity and enhancement of operational efficiency," Eris Lifesciences Executive Director & Chief Operating Officer Krishnakumar V stated.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)